Correlation Between Exelixis and ProQR Therapeutics

Can any of the company-specific risk be diversified away by investing in both Exelixis and ProQR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and ProQR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Exelixis and ProQR Therapeutics BV, you can compare the effects of market volatilities on Exelixis and ProQR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of ProQR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and ProQR Therapeutics.

Diversification Opportunities for Exelixis and ProQR Therapeutics

-0.49

Correlation Coefficient

Exelixis  ProQR Therapeutics

Very good diversification

The 3 months correlation between Exelixis and ProQR is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and ProQR Therapeutics BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProQR Therapeutics and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with ProQR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProQR Therapeutics has no effect on the direction of Exelixis i.e., Exelixis and ProQR Therapeutics go up and down completely randomly.

Pair Corralation between Exelixis and ProQR Therapeutics

Given the investment horizon of 90 days Exelixis is expected to generate 0.62 times more return on investment than ProQR Therapeutics. However, Exelixis is 1.61 times less risky than ProQR Therapeutics. It trades about 0.07 of its potential returns per unit of risk. ProQR Therapeutics BV is currently generating about -0.24 per unit of risk. If you would invest  3,370  in Exelixis on December 29, 2024 and sell it today you would earn a total of  314.00  from holding Exelixis or generate 9.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Exelixis  vs.  ProQR Therapeutics BV

Exelixis

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Exelixis may actually be approaching a critical reversion point that can send shares even higher in April 2025.

ProQR Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days ProQR Therapeutics BV has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Exelixis and ProQR Therapeutics

The main advantage of trading using opposite Exelixis and ProQR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, ProQR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will offset losses from the drop in ProQR Therapeutics' long position.

The idea behind Exelixis and ProQR Therapeutics BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.